Cas:78587-05-0 Hexythiazox manufacturer & supplier

Chemical Name:Hexythiazox

CAS.NO:78587-05-0

Synonyms:Hexygon,Acariflor,Calibre;Savey;Matacar;Nissorun;3-Thiazolidinecarboxamide, 5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-;Acarflor;Acariflor;Trevi;(4S,5S)-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-1,3-thiazolidine-3-carboxamide;Calibre;MFCD00137385;5-(4-Chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-1,3-thiazolidine-3-carboxamide;Hexythiazox;rac-(4R,5R)-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-1,3-thiazolidine-3-carboxamide;(4R,5R)-rel-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidinecarboxamide;Ordoval;Cesar;(4RS,5RS)-5-(4-Chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-1,3-thiazolidine-3-carboxamide

Molecular Formula:C₁₇H₂₁ClN₂O₂S

Molecular Weight:352.879

HS Code:2934100011

Physical and Chemical Properties:

Melting point:108-108.5°C

Boiling point:N/A

Density:1.3±0.1 g/cm3

Index of Refraction:1.621

PSA:74.71000

Exact Mass:352.101227

LogP:3.41

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3077

Packing Group:

Contact us for information like Hexygon,Acariflor,Calibre chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4RS,5RS)-5-(4-Chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-1,3-thiazolidine-3-carboxamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(4-Chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-1,3-thiazolidine-3-carboxamide Use and application,Hexygon,Acariflor,Calibre technical grade,usp/ep/jp grade.

Related News: Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells. Hexythiazox manufacturer The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting. Hexythiazox supplier The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. Hexythiazox vendor Aduhelm, however, is in a different league in terms of the number of potential patients and cost to the healthcare system. Hexythiazox factory The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting.